Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo 31P magnetic resonance spectroscopy study
Francesco Papalia, Fadi Jouhra, George Amin‐Youssef, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 4, pp. 716-723
Open Access | Times Cited: 20

Showing 20 citing articles:

SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism
Milton Packer
Nature Reviews Cardiology (2023) Vol. 20, Iss. 7, pp. 443-462
Open Access | Times Cited: 103
Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in Combination in Heart Failure
Milton Packer
JACC Heart Failure (2022) Vol. 11, Iss. 1, pp. 106-114
Open Access | Times Cited: 50
How can sodium–glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron‐deficient? Implications for understanding iron homeostasis in heart failure
Milton Packer
European Journal of Heart Failure (2022) Vol. 24, Iss. 12, pp. 2287-2296
Open Access | Times Cited: 47
Critical re‐evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure
Milton Packer, Stefan D. Anker, Javed Butler, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1298-1312
Open Access | Times Cited: 7
Identification of three mechanistic pathways for iron-deficient heart failure
Milton Packer, Stefan D. Anker, Javed Butler, et al.
European Heart Journal (2024) Vol. 45, Iss. 26, pp. 2281-2293
Open Access | Times Cited: 6
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial
Christiane E. Angermann, Susanne Sehner, Louisa M.S. Gerhardt, et al.
European Heart Journal (2024)
Open Access | Times Cited: 5
Pre-emptive iron supplementation prevents myocardial iron deficiency and attenuates adverse remodelling after myocardial infarction
Bomee Chung, Yong Wang, Marleen Thiel, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 10, pp. 1969-1980
Closed Access | Times Cited: 12
Maintaining energy provision in the heart: the creatine kinase system in ischaemia–reperfusion injury and chronic heart failure
Craig A. Lygate
Clinical Science (2024) Vol. 138, Iss. 8, pp. 491-514
Open Access | Times Cited: 4
Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Feng Zhang, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access
Effects of Intravenous Iron Replacement Therapy on Cardiovascular Outcomes in Patients with Heart Failure: A Systematic Review and Meta-Analysis
Johannes Reinhold, Vyas Burra, Natasha Corballis, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 3, pp. 116-116
Open Access | Times Cited: 7
Intravenous iron repletion in heart failure: bridging the gap between symptom relief and hard clinical outcomes
Huda Abu‐Own, Ian Webb, Darlington O. Okonko
European Heart Journal (2023) Vol. 44, Iss. 48, pp. 5092-5094
Open Access | Times Cited: 4
Iron Deficiency in Chronic Pediatric Heart Failure: Overall Assessment and Outcomes in Dilated Cardiomyopathy
Lia Phillips, Marc E. Richmond, Cindy Neunert, et al.
The Journal of Pediatrics (2023) Vol. 263, pp. 113721-113721
Closed Access | Times Cited: 2
The Impact of Iron Deficiency on Disease Severity and Myocardial Function in Cardiac Amyloidosis
Pieter Martens, Lauren Ives, Christopher Nguyen, et al.
American Journal of Medicine Open (2023) Vol. 11, pp. 100063-100063
Open Access | Times Cited: 2
The Cdc42/Rac1 pathway: a molecular mechanism behind iron-deficiency-driven aortic medial degeneration
Shaohua Wang, Hengjuan Liu, Junxia Hu, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 8, pp. 3922-3937
Open Access
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction
Daniela Tomasoni, Marianna Adamo, Marco Metra
European Journal of Heart Failure (2022) Vol. 24, Iss. 4, pp. 593-595
Closed Access | Times Cited: 1
Spot Urinary Creatinine Concentration in Patients with Chronic Heart Failure Identifies a Distinct Muscle-Wasting Phenotype with a Strikingly Different Risk of Mortality
Jolanta Malinowska-Borowska, Marta Buczkowska, Sylwia Duda, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2342-2342
Open Access
The heart during iron deficiency: a non‐rechargeable battery?
Niels Grote Beverborg
European Journal of Heart Failure (2022) Vol. 24, Iss. 4, pp. 724-726
Open Access
Letter regarding the article ‘Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo31P magnetic resonance spectroscopy study’
Matthew K. Burrage, Ladislav Valkovič, Oliver J. Rider
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1992-1992
Open Access
Reply to the letter regarding the article ‘Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo31P magnetic resonance spectroscopy study’
Francesco Papalia, Geoff Charles‐Edwards, Darlington O. Okonko
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1992-1993
Closed Access
Iron Deficiency in Heart Failure: What Do We Know So Far?
Amr Elkammash, Rasha M Farahat, Aya Al Sattouf, et al.
Cureus (2022)
Open Access
Page 1

Scroll to top